We are live on ! Find out more
VRS

Verso Corporation

Delisted

VRS was delisted on the 30th of March, 2022.

112 hedge funds and large institutions have $413M invested in Verso Corporation in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 25 increasing their positions, 47 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

436% more call options, than puts

Call options by funds: $5.31M | Put options by funds: $991K

31% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 16

13% more capital invested

Capital invested by funds: $366M → $413M (+$46.6M)

4% more funds holding

Funds holding: 108112 (+4)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

47% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 47

Holders
112
Holders Change
+4
Holders Change %
+3.7%
% of All Funds
1.96%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
21
Increased
25
Reduced
47
Closed
16
Calls
$5.31M
Puts
$991K
Net Calls
+$4.32M
Net Calls Change
+$351K
Name Holding Trade Value Shares
Change
Change in
Stake
SO
51
STRS Ohio
Ohio
$852K -$90.7K -4,700 -10%
LSV Asset Management
52
LSV Asset Management
Illinois
$832K
Barclays
53
Barclays
United Kingdom
$822K +$681K +35,316 +825%
PPA
54
Parametric Portfolio Associates
Washington
$820K -$40.4K -2,095 -5%
AQR Capital Management
55
AQR Capital Management
Connecticut
$785K -$570K -29,557 -44%
PM
56
Precept Management
Texas
$695K
SFI
57
Susquehanna Fundamental Investments
Pennsylvania
$645K +$5.21K +270 +0.9%
IA
58
IndexIQ Advisors
New York
$639K +$59.5K +3,087 +11%
AC
59
Aristides Capital
Kentucky
$612K +$138K +7,144 +32%
Ensign Peak Advisors
60
Ensign Peak Advisors
Utah
$577K
Qube Research & Technologies (QRT)
61
Qube Research & Technologies (QRT)
United Kingdom
$566K +$526K +27,264 New
ERSOT
62
Employees Retirement System of Texas
Texas
$558K +$519K +26,884 New
T. Rowe Price Associates
63
T. Rowe Price Associates
Maryland
$543K -$55.3K -2,868 -10%
CSS
64
Cubist Systematic Strategies
Connecticut
$522K -$22.1K -1,148 -4%
First Manhattan
65
First Manhattan
New York
$518K -$166K -8,600 -26%
PP
66
PDT Partners
New York
$517K -$108K -5,600 -18%
WG
67
Winton Group
United Kingdom
$517K -$9.53K -494 -2%
E
68
Ergoteles
New York
$448K -$136K -7,039 -25%
New York State Common Retirement Fund
69
New York State Common Retirement Fund
New York
$415K -$102K -5,287 -21%
EC
70
EJF Capital
Virginia
$415K +$154K +8,000 +67%
IIM
71
Ironwood Investment Management
Massachusetts
$409K
State Board of Administration of Florida Retirement System
72
State Board of Administration of Florida Retirement System
Florida
$346K
SG Americas Securities
73
SG Americas Securities
New York
$346K +$322K +16,695 New
Bank of America
74
Bank of America
North Carolina
$332K -$180K -9,310 -37%
JF
75
Jump Financial
Illinois
$324K +$301K +15,600 New

VRS Hedge Fund Activity: Q3 2021 in Review

112 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Verso Corporation (VRS) for Q3 2021, worth a combined $413M — up 13% from $366M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new VRS positions and 16 closed out — a net gain of 5 holders — while 25 added to existing stakes and 47 trimmed.

The largest buyer was Mangrove Partners, opening a new position worth an estimated $3.15M. The largest seller was Redwood Capital Management, exiting entirely with an estimated $4.41M sold.

  • 112 institutional investors held Verso Corporation (VRS) as of Q3 2021, up from 108 in Q2 2021.
  • Funds reported $413M of Verso Corporation stock for Q3 2021, up 13% quarter-over-quarter.
  • 21 funds opened new Verso Corporation positions in Q3 2021 and 16 closed out, a net change of +5 holders.
  • The largest Verso Corporation buyer in Q3 2021 was Mangrove Partners, an estimated $3.15M added.
  • The largest Verso Corporation seller in Q3 2021 was Redwood Capital Management, an estimated $4.41M sold.

Based on aggregated 13F filings for Q3 2021.